District Judge Karen Marston has held the initial case management conference for the newly formed multidistrict litigation involving claims of vision loss tied to Ozempic and other GLP-1 receptor agonist drugs
The available data comes from company-run in-vitro assays, animal safety and toxicity studies, and anecdotal user reports
Book a free 15-minute consultation with Esther Yunkin, RN , Learn more about your options and get personalized guidance
There are no restrictions or risks based upon skin tone or type with VelaShape, as it is not a laser
Levia works through a steady transdermal delivery system that allows active ingredients to be absorbed through the skin over several hours
The urticaria developed within minutes after the last dose of injection on the 7th day of treatment, presumably after a 1 week sensitization period